{"hands_on_practices": [{"introduction": "One of the most critical early events in severe acute pancreatitis is a massive fluid shift from the bloodstream into the surrounding tissues, a process known as \"third-spacing.\" This practice demonstrates how routine laboratory tests, such as hematocrit and Blood Urea Nitrogen (BUN), serve as vital indicators of this dangerous fluid loss. By working through this scenario [@problem_id:4758688], you will learn to connect these lab values to the underlying pathophysiology of hemoconcentration and even estimate the volume of intravascular fluid deficit.", "problem": "An adult male with severe acute pancreatitis is observed during the first day of illness. Within the first $24$ hours, there is prominent third spacing of fluid into the peripancreatic and retroperitoneal interstitium. You are told the following serial measurements and baseline characteristics:\n\n- Baseline hematocrit measured $1$ week prior: $H_0 = 0.40$.\n- Baseline Blood Urea Nitrogen (BUN): $C_{\\mathrm{BUN},0} = 12\\,\\text{mg/dL}$.\n- Body mass: $75\\,\\text{kg}$, male.\n- At $\\;6\\,\\text{hours}$: hematocrit $H_{6} = 0.48$, BUN $C_{\\mathrm{BUN},6} = 24\\,\\text{mg/dL}$.\n- At $\\;24\\,\\text{hours}$: hematocrit $H_{24} = 0.46$, BUN $C_{\\mathrm{BUN},24} = 28\\,\\text{mg/dL}$.\n\nUse the following context-appropriate fundamental bases and assumptions:\n\n- Red blood cell (RBC) volume $V_{\\mathrm{RBC}}$ is approximately conserved over the first day, because RBC mass does not change acutely in the absence of hemorrhage or transfusion.\n- Hematocrit $H$ is defined as $H = \\dfrac{V_{\\mathrm{RBC}}}{V_{\\mathrm{RBC}} + V_{\\mathrm{plasma}}}$, where $V_{\\mathrm{plasma}}$ is the intravascular plasma volume.\n- Baseline total blood volume $BV_0$ for an adult male can be estimated by the well-tested approximation $BV_0 \\approx 70\\,\\text{mL/kg} \\times (\\text{body mass})$.\n- Blood Urea Nitrogen (BUN) concentration $C_{\\mathrm{BUN}}$ reflects the balance $\\dfrac{dN}{dt} = P - \\mathrm{Cl}\\cdot C_{\\mathrm{BUN}}$, where $N$ is the mass of urea in the intravascular compartment, $P$ is the hepatic production rate of urea (approximately constant over short intervals), and $\\mathrm{Cl}$ is the effective renal clearance that depends on renal perfusion. Over short intervals of hypovolemia, assume $\\mathrm{Cl}$ scales with effective renal plasma flow, which is monotone increasing in $V_{\\mathrm{plasma}}$.\n\nTasks:\n\n1. Starting from the conservation of $V_{\\mathrm{RBC}}$ and the definition of hematocrit, derive why an increase in $H$ within $24$ hours indicates hemoconcentration due to a decrease in $V_{\\mathrm{plasma}}$ from third spacing of fluid.\n2. Using the mass-balance expression for Blood Urea Nitrogen (BUN) given above, reason from first principles why early increases in $C_{\\mathrm{BUN}}$ are expected when intravascular plasma volume falls, even if urea production $P$ is unchanged.\n3. Using the measured hematocrits and the assumptions provided, compute the intravascular plasma volume deficit at $24\\,\\text{hours}$ relative to baseline, expressed as a positive magnitude. Use the baseline hematocrit $H_0$ and $BV_0$ to determine $V_{\\mathrm{RBC}}$ and $V_{\\mathrm{plasma},0}$, then use $H_{24}$ to determine $V_{\\mathrm{plasma},24}$, and report the deficit $\\Delta V_{\\mathrm{plasma}} = V_{\\mathrm{plasma},0} - V_{\\mathrm{plasma},24}$. Express the final volume deficit in liters, and round your answer to three significant figures.", "solution": "The user has provided a multi-part problem concerning the pathophysiology of severe acute pancreatitis. The problem has been validated and found to be scientifically grounded, well-posed, and objective. It contains sufficient information for a complete solution.\n\nThe problem will be addressed in three parts as requested.\n\nPart 1: The relationship between hematocrit ($H$) and plasma volume ($V_{\\mathrm{plasma}}$).\n\nThe hematocrit is defined as the ratio of the volume of red blood cells ($V_{\\mathrm{RBC}}$) to the total blood volume ($BV$), which is the sum of $V_{\\mathrm{RBC}}$ and the plasma volume, $V_{\\mathrm{plasma}}$.\n$$H = \\frac{V_{\\mathrm{RBC}}}{BV} = \\frac{V_{\\mathrm{RBC}}}{V_{\\mathrm{RBC}} + V_{\\mathrm{plasma}}}$$\nThe problem states the critical assumption that $V_{\\mathrm{RBC}}$ is conserved over the first $24$ hours in the absence of hemorrhage or transfusion. This means $V_{\\mathrm{RBC}}$ can be treated as a positive constant. We can rearrange the definition of hematocrit to express $V_{\\mathrm{plasma}}$ as a function of $H$.\n$$H(V_{\\mathrm{RBC}} + V_{\\mathrm{plasma}}) = V_{\\mathrm{RBC}}$$\n$$H \\cdot V_{\\mathrm{RBC}} + H \\cdot V_{\\mathrm{plasma}} = V_{\\mathrm{RBC}}$$\n$$H \\cdot V_{\\mathrm{plasma}} = V_{\\mathrm{RBC}} - H \\cdot V_{\\mathrm{RBC}}$$\n$$V_{\\mathrm{plasma}} = V_{\\mathrm{RBC}} \\left(\\frac{1 - H}{H}\\right)$$\nTo understand how $V_{\\mathrm{plasma}}$ changes when $H$ changes, we can examine the derivative of $V_{\\mathrm{plasma}}$ with respect to $H$, treating $V_{\\mathrm{RBC}}$ as a constant.\n$$\\frac{d V_{\\mathrm{plasma}}}{d H} = V_{\\mathrm{RBC}} \\frac{d}{d H} \\left(\\frac{1}{H} - 1\\right) = V_{\\mathrm{RBC}} \\left(-\\frac{1}{H^2}\\right)$$\nSince $V_{\\mathrm{RBC}}$ is a positive volume and $H^2$ is always positive, the derivative $\\frac{d V_{\\mathrm{plasma}}}{d H}$ is always negative for any valid hematocrit ($0  H  1$). This inverse relationship means that an increase in hematocrit ($H$) must correspond to a decrease in plasma volume ($V_{\\mathrm{plasma}}$). This phenomenon, a reduction in the fluid component of the blood leading to a higher concentration of red blood cells, is known as hemoconcentration. In the context of acute pancreatitis, this is caused by a massive inflammatory response leading to increased capillary permeability and the \"third spacing\" of plasma-rich fluid into the retroperitoneal and peripancreatic spaces.\n\nPart 2: The mechanism for an increase in Blood Urea Nitrogen ($C_{\\mathrm{BUN}}$).\n\nThe mass balance for urea in the intravascular compartment is given by the differential equation:\n$$\\frac{dN}{dt} = P - \\mathrm{Cl}\\cdot C_{\\mathrm{BUN}}$$\nwhere $N$ is the mass of urea, $P$ is the constant hepatic production rate, $\\mathrm{Cl}$ is the renal clearance, and $C_{\\mathrm{BUN}}$ is the urea concentration. At a physiological steady state, the rate of change $\\frac{dN}{dt}$ is approximately zero, implying that production equals clearance: $P \\approx \\mathrm{Cl} \\cdot C_{\\mathrm{BUN}}$. From this, the steady-state concentration is $C_{\\mathrm{BUN}} \\approx \\frac{P}{\\mathrm{Cl}}$.\n\nThe problem states that in acute pancreatitis, there is a fall in intravascular plasma volume, $V_{\\mathrm{plasma}}$. It is a fundamental principle of renal physiology that renal blood flow, and consequently renal plasma flow, is dependent on the systemic intravascular volume and arterial pressure. The effective renal clearance of urea ($\\mathrm{Cl}$) is directly dependent on renal perfusion. The problem codifies this by stating that $\\mathrm{Cl}$ is a monotone increasing function of $V_{\\mathrm{plasma}}$.\n\nTherefore, as $V_{\\mathrm{plasma}}$ decreases due to third spacing, renal perfusion diminishes, causing a decrease in the renal clearance, $\\mathrm{Cl}$. With a now-reduced $\\mathrm{Cl}$ and a constant production rate $P$, the removal term $\\mathrm{Cl} \\cdot C_{\\mathrm{BUN}}$ becomes smaller than $P$. This makes the rate of change of urea mass, $\\frac{dN}{dt}$, positive, meaning the total mass $N$ of urea in the body begins to accumulate.\n\nThe concentration $C_{\\mathrm{BUN}}$ is the mass $N$ divided by the volume it is distributed in, which for the purposes of this model is related to $V_{\\mathrm{plasma}}$. The rise in $C_{\\mathrm{BUN}}$ is thus driven by two factors:\n1.  **Decreased Clearance**: The primary driver is the reduction in $\\mathrm{Cl}$, which leads to a net accumulation of urea mass ($N$) over time.\n2.  **Volume Contraction**: The accumulated urea mass is now dissolved in a smaller plasma volume $V_{\\mathrm{plasma}}$, which further elevates its concentration ($C_{\\mathrm{BUN}} = N / V_{\\mathrm{plasma}}$).\n\nThis condition, where BUN rises due to factors \"before\" the kidney (i.e., reduced renal perfusion) rather than intrinsic kidney disease, is known as prerenal azotemia.\n\nPart 3: Calculation of the plasma volume deficit.\n\nFirst, we calculate the baseline total blood volume, $BV_0$, for the $75\\,\\text{kg}$ male patient.\n$$BV_0 = (70\\,\\text{mL/kg}) \\times (75\\,\\text{kg}) = 5250\\,\\text{mL}$$\nNext, we determine the baseline red blood cell volume, $V_{\\mathrm{RBC}}$, and plasma volume, $V_{\\mathrm{plasma},0}$, using the baseline hematocrit $H_0 = 0.40$.\n$$V_{\\mathrm{RBC}} = H_0 \\cdot BV_0 = 0.40 \\times 5250\\,\\text{mL} = 2100\\,\\text{mL}$$\nThis volume of red blood cells, $V_{\\mathrm{RBC}} = 2100\\,\\text{mL}$, is assumed to be conserved. The baseline plasma volume is:\n$$V_{\\mathrm{plasma},0} = BV_0 - V_{\\mathrm{RBC}} = 5250\\,\\text{mL} - 2100\\,\\text{mL} = 3150\\,\\text{mL}$$\nNow, we calculate the plasma volume at $24$ hours, $V_{\\mathrm{plasma},24}$, using the hematocrit at $24$ hours, $H_{24} = 0.46$, and the conserved $V_{\\mathrm{RBC}}$. We use the formula derived in Part 1.\n$$V_{\\mathrm{plasma},24} = V_{\\mathrm{RBC}} \\left(\\frac{1 - H_{24}}{H_{24}}\\right)$$\n$$V_{\\mathrm{plasma},24} = 2100\\,\\text{mL} \\left(\\frac{1 - 0.46}{0.46}\\right) = 2100\\,\\text{mL} \\left(\\frac{0.54}{0.46}\\right)$$\n$$V_{\\mathrm{plasma},24} \\approx 2100\\,\\text{mL} \\times 1.173913 \\approx 2465.217\\,\\text{mL}$$\nThe plasma volume deficit, $\\Delta V_{\\mathrm{plasma}}$, is the difference between the baseline and $24$-hour plasma volumes.\n$$\\Delta V_{\\mathrm{plasma}} = V_{\\mathrm{plasma},0} - V_{\\mathrm{plasma},24}$$\n$$\\Delta V_{\\mathrm{plasma}} = 3150\\,\\text{mL} - 2465.217\\,\\text{mL} = 684.783\\,\\text{mL}$$\nThe problem asks for the result to be expressed in liters, rounded to three significant figures.\n$$\\Delta V_{\\mathrm{plasma}} = 0.684783\\,\\text{L}$$\nRounding to three significant figures, we get $0.685\\,\\text{L}$.", "answer": "$$\\boxed{0.685}$$", "id": "4758688"}, {"introduction": "After identifying key pathophysiological changes like third-spacing, clinicians must synthesize multiple data points to rapidly assess a patient's overall risk and prognosis. This exercise introduces the Bedside Index for Severity in Acute Pancreatitis (BISAP) score, a powerful and practical prognostic tool. By applying the BISAP criteria to a clinical vignette [@problem_id:4880404], you will practice integrating diverse findings—from vital signs and lab results to age and physical exam—to stratify disease severity and guide critical care decisions.", "problem": "A patient with acute pancreatitis is evaluated within the first $24$ hours of hospital admission. You are asked to compute the Bedside Index for Severity in Acute Pancreatitis (BISAP) score from first principles by assessing blood urea nitrogen, mental status, systemic inflammatory response, age, and pleural effusion using widely accepted clinical definitions. Then, infer the qualitative in-hospital mortality risk category from the computed BISAP score. Finally, report only the BISAP score as your final numeric answer.\n\nClinical vignette: A $68$-year-old man with a history of heavy alcohol use presents with severe epigastric pain radiating to the back and vomiting for $10$ hours. On arrival, vital signs are: temperature $38.7^{\\circ}\\mathrm{C}$, heart rate $112/\\mathrm{min}$, respiratory rate $24/\\mathrm{min}$, blood pressure $98/64\\ \\mathrm{mmHg}$, and oxygen saturation $0.93$ on room air. Initial laboratory results: white blood cell count $13.2 \\times 10^{9}/\\mathrm{L}$ with band forms $12\\%$, blood urea nitrogen $32\\ \\mathrm{mg/dL}$, creatinine $1.2\\ \\mathrm{mg/dL}$, serum sodium $137\\ \\mathrm{mmol/L}$, and arterial partial pressure of carbon dioxide ($\\text{PaCO}_2$) of $30\\ \\mathrm{mmHg}$. Neurologic evaluation shows a Glasgow Coma Scale (GCS) score of $13$. A chest radiograph demonstrates a small left pleural effusion. Serum lipase is elevated above the diagnostic threshold for acute pancreatitis.\n\nTask: Using established definitions of systemic inflammatory response syndrome (SIRS) and impaired mental status as defined by the Glasgow Coma Scale, compute the BISAP score for this patient within the first $24$ hours and infer the qualitative in-hospital mortality risk category associated with that score. Express the final BISAP score as a single integer with no units. No rounding is necessary for the final reported value.", "solution": "The problem statement has been critically evaluated and is deemed valid. It is scientifically grounded in established medical principles, well-posed with sufficient data to compute the Bedside Index for Severity in Acute Pancreatitis (BISAP) score, and presented objectively. The task requires the application of a standard clinical scoring system to a realistic patient vignette.\n\nThe BISAP score is a clinical tool used to predict in-hospital mortality in patients with acute pancreatitis. It is calculated within the first $24$ hours of admission and consists of five components, each assigned one point if the specified criterion is met. The total score ranges from $0$ to $5$. The acronym BISAP corresponds to:\n- **B**: Blood Urea Nitrogen (BUN)\n- **I**: Impaired Mental Status\n- **S**: Systemic Inflammatory Response Syndrome (SIRS)\n- **A**: Age\n- **P**: Pleural Effusion\n\nWe will now evaluate each component based on the provided clinical data.\n\n1.  **Blood Urea Nitrogen (B)**: The criterion for this point is a BUN level greater than $25\\ \\mathrm{mg/dL}$. The patient's initial laboratory results show a BUN of $32\\ \\mathrm{mg/dL}$. Since $32 > 25$, this criterion is met.\n    Score for B = $1$ point.\n\n2.  **Impaired Mental Status (I)**: The criterion for this point is evidence of impaired mental status, which is defined as a Glasgow Coma Scale (GCS) score less than $15$. The patient's neurologic evaluation yielded a GCS score of $13$. Since $13  15$, this criterion is met.\n    Score for I = $1$ point.\n\n3.  **Systemic Inflammatory Response Syndrome (SIRS) (S)**: The criterion for this point is the presence of SIRS. SIRS is clinically defined by the presence of at least two of the following four criteria:\n    a) Temperature less than $36^{\\circ}\\mathrm{C}$ or greater than $38^{\\circ}\\mathrm{C}$. The patient's temperature is $38.7^{\\circ}\\mathrm{C}$, which is greater than $38^{\\circ}\\mathrm{C}$. This condition is met.\n    b) Heart rate greater than $90$ beats/min. The patient's heart rate is $112/\\mathrm{min}$, which is greater than $90/\\mathrm{min}$. This condition is met.\n    c) Respiratory rate greater than $20$ breaths/min or an arterial partial pressure of carbon dioxide ($\\text{PaCO}_2$) less than $32\\ \\mathrm{mmHg}$. The patient's respiratory rate is $24/\\mathrm{min}$, which is greater than $20/\\mathrm{min}$. Additionally, the $\\text{PaCO}_2$ is $30\\ \\mathrm{mmHg}$, which is less than $32\\ \\mathrm{mmHg}$. This condition is met.\n    d) White blood cell (WBC) count less than $4 \\times 10^{9}/\\mathrm{L}$, greater than $12 \\times 10^{9}/\\mathrm{L}$, or greater than $10\\%$ immature band forms. The patient's WBC count is $13.2 \\times 10^{9}/\\mathrm{L}$, which is greater than $12 \\times 10^{9}/\\mathrm{L}$. Additionally, the patient has $12\\%$ band forms, which is greater than $10\\%$. This condition is met.\n\n    The patient satisfies all four criteria for SIRS. Since only two are required, SIRS is present.\n    Score for S = $1$ point.\n\n4.  **Age (A)**: The criterion for this point is an age greater than $60$ years. The patient is $68$ years old. Since $68 > 60$, this criterion is met.\n    Score for A = $1$ point.\n\n5.  **Pleural Effusion (P)**: The criterion for this point is the presence of a pleural effusion on any imaging study. The chest radiograph report explicitly states \"a small left pleural effusion\". This criterion is met.\n    Score for P = $1$ point.\n\nThe total BISAP score is the sum of the points from each component:\nTotal BISAP Score = (B score) + (I score) + (S score) + (A score) + (P score)\nTotal BISAP Score = $1 + 1 + 1 + 1 + 1 = 5$.\n\nAn increasing BISAP score correlates with a higher risk of in-hospital mortality. A score of $0$ to $2$ is associated with a mortality rate of less than $2\\%$, whereas scores of $3$, $4$, and $5$ are associated with progressively higher mortality, with a score of $5$ having a mortality rate approaching $22\\%$. Therefore, this patient's score of $5$ places them in the highest risk category for in-hospital mortality.\n\nThe final task is to report only the computed BISAP score.", "answer": "$$\n\\boxed{5}\n$$", "id": "4880404"}, {"introduction": "Moving from the acute setting to the long-term consequences of pancreatic disease, this problem addresses a key complication of chronic pancreatitis: exocrine pancreatic insufficiency. This condition occurs when the damaged pancreas can no longer produce enough digestive enzymes, leading to maldigestion. This hands-on calculation [@problem_id:5190260] will guide you through the principles of Pancreatic Enzyme Replacement Therapy (PERT), illustrating how clinicians translate physiological needs into a precise therapeutic regimen to manage this chronic condition effectively.", "problem": "A child with chronic pancreatitis has exocrine pancreatic insufficiency requiring Pancreatic Enzyme Replacement Therapy (PERT). Assume the following foundational clinical facts: dosing targets are proportional to body weight for each feeding, snacks require approximately half the lipase exposure of full meals, and the fraction of administered lipase that reaches the duodenum intact is reduced by gastric acid but improved by acid suppression. Let the target effective lipase exposure per full meal be $2000\\,\\text{lipase units/kg/meal}$ and per snack be one-half of the full-meal target. The child weighs $20\\,\\text{kg}$ and eats $3$ full meals and $2$ snacks per day. For this patient, acid suppression increases the fraction of administered lipase that remains intact and active at the duodenum from $0.80$ to $0.90$. A daily safety cap of $10000\\,\\text{lipase units/kg/day}$ applies; if the calculated requirement exceeds the cap, the cap determines the prescribed total.\n\nStarting from first principles of mass balance (effective exposure equals administered dose multiplied by the fraction that survives to the duodenum), derive the total daily administered lipase units required to meet the effective exposure targets for all feedings under acid suppression. Express your final answer in lipase units and round your answer to four significant figures.", "solution": "The problem is valid as it is scientifically grounded in established clinical principles of Pancreatic Enzyme Replacement Therapy (PERT), is well-posed with sufficient and consistent data, and is expressed in objective, formalizable language.\n\nThe solution is derived from the first principle of mass balance provided, which relates the effective lipase exposure to the administered dose and its survival fraction. Let $L_{eff}$ be the effective lipase exposure, $L_{admin}$ be the administered lipase dose, and $f$ be the fraction of administered lipase that remains intact and active. The relationship is:\n$$L_{eff} = L_{admin} \\times f$$\nTo determine the required administered dose to achieve a target effective exposure, this equation is rearranged:\n$$L_{admin} = \\frac{L_{eff}}{f}$$\n\nFirst, we define the given parameters symbolically:\n-   Target effective lipase exposure per full meal: $T_{meal} = 2000\\,\\text{lipase units/kg/meal}$\n-   Target effective lipase exposure per snack: $T_{snack} = \\frac{1}{2} T_{meal}$\n-   Child's body weight: $W = 20\\,\\text{kg}$\n-   Number of full meals per day: $N_{meals} = 3$\n-   Number of snacks per day: $N_{snacks} = 2$\n-   Fraction of lipase surviving with acid suppression: $f_{supp} = 0.90$\n-   Daily safety cap on administered dose per unit weight: $C_{admin, daily} = 10000\\,\\text{lipase units/kg/day}$\n\nThe goal is to find the total daily administered lipase units, which we will denote as $L_{admin, total}$.\n\nFirst, we calculate the total target *effective* lipase exposure for the child per day, $E_{total, daily}$. This is the sum of the exposure required for all meals and snacks.\n\nThe target effective exposure for one full meal is:\n$$E_{meal} = T_{meal} \\times W$$\nThe target effective exposure for one snack is:\n$$E_{snack} = T_{snack} \\times W = \\left(\\frac{1}{2} T_{meal}\\right) \\times W$$\nThe total daily target effective exposure is the sum over all feedings:\n$$E_{total, daily} = (N_{meals} \\times E_{meal}) + (N_{snacks} \\times E_{snack})$$\nSubstituting the expressions for $E_{meal}$ and $E_{snack}$:\n$$E_{total, daily} = (N_{meals} \\times T_{meal} \\times W) + \\left(N_{snacks} \\times \\frac{1}{2} T_{meal} \\times W\\right)$$\nFactoring out $T_{meal}$ and $W$:\n$$E_{total, daily} = T_{meal} \\times W \\times \\left(N_{meals} + \\frac{N_{snacks}}{2}\\right)$$\nSubstituting the numerical values:\n$$E_{total, daily} = (2000) \\times (20) \\times \\left(3 + \\frac{2}{2}\\right)$$\n$$E_{total, daily} = 40000 \\times (3 + 1) = 40000 \\times 4 = 160000\\,\\text{lipase units/day}$$\n\nNext, we calculate the total *administered* lipase dose, $L_{admin, total}$, required to achieve this effective exposure under acid suppression, using the survival fraction $f_{supp} = 0.90$.\n$$L_{admin, total} = \\frac{E_{total, daily}}{f_{supp}}$$\nSubstituting the value for $E_{total, daily}$:\n$$L_{admin, total} = \\frac{160000}{0.90} \\approx 177777.77...\\,\\text{lipase units/day}$$\n\nNow, we must check if this calculated dose exceeds the daily safety cap. The cap is given per kilogram of body weight, so we calculate the total cap for this child, $C_{total}$.\n$$C_{total} = C_{admin, daily} \\times W$$\nSubstituting the numerical values:\n$$C_{total} = 10000\\,\\text{lipase units/kg/day} \\times 20\\,\\text{kg} = 200000\\,\\text{lipase units/day}$$\n\nThe prescribed dose is the minimum of the calculated required dose and the safety cap. We compare $L_{admin, total}$ with $C_{total}$:\n$$177777.77...  200000$$\nThe calculated required dose is less than the daily safety cap. Therefore, the prescribed dose is the calculated dose.\n$$L_{prescribed} = L_{admin, total} \\approx 177777.77...\\,\\text{lipase units}$$\n\nThe problem requires the final answer to be rounded to four significant figures. The number is $177777.77...$. The first four significant digits are $1$, $7$, $7$, $7$. The fifth digit is $7$, which is greater than or equal to $5$, so we round up the fourth digit.\n$$1777... \\rightarrow 1778$$\nThe final rounded answer is $177800$. Expressed in scientific notation, this is $1.778 \\times 10^5$.", "answer": "$$\\boxed{1.778 \\times 10^{5}}$$", "id": "5190260"}]}